Core Insights - The strategic partnership between Kefu and Taobao Flash aims to transform the online pharmaceutical purchasing model and enhance self-health management solutions for consumers [1] Group 1: Partnership Overview - Kefu has over 135 years of experience in the consumer health sector and owns several well-known brands such as Tylenol and Listerine, which are trusted by consumers and professionals alike [1] - The collaboration will leverage Kefu's brand influence and Taobao Flash's platform advantages to expand consumer reach and promote scientific health management concepts [1] Group 2: Focus Areas of Collaboration - The partnership will focus on mutual user growth by integrating Taobao Flash's membership benefits and expanding the potential consumer base [1] - Kefu and Taobao Flash will enhance brand collaboration efforts to achieve sustained mutual benefits [1] Group 3: Technological Integration - Taobao Flash's "AI Find Medicine" service will provide a comprehensive solution from medication selection to purchase, supported by Kefu's extensive knowledge in disease management and medication plans [2] - Kefu will be the first brand to share API data with Taobao Flash, enabling real-time supply monitoring and improving market coverage [2] Group 4: Future Goals - The partnership aims to enhance data sharing and intelligent analysis to predict stock shortages and ensure the availability of health products [2] - Both companies are committed to providing high-quality health products and self-diagnosis services to a broader consumer base [2]

Core Insights - The company reported significant growth in both revenue and profit for the fiscal year 2024, with total revenue reaching 1.766 billion yuan, a year-on-year increase of 29.26%, and net profit attributable to shareholders at 106 million yuan, up 94.58% [1] - In Q1 2025, the company continued its growth trajectory, achieving revenue of 574 million yuan, a 54.16% increase year-on-year, and a net profit of 27.42 million yuan, up 113.88% [1] Business Performance - The company's self-owned brand business generated revenue of 501 million yuan in 2024, marking a 90.28% increase and accounting for 28.37% of total revenue [1] - The brand "Zhanjia" has shown exceptional growth, with its total sales doubling year-on-year across multiple channels, including Tmall, Douyin, and Xiaohongshu, with GMV growth exceeding 100% [1] - The newly launched health brand "FineNutri" has rapidly gained traction, ranking second in Tmall's oral beauty nutrition category and first in the health supplement store heat ranking as of March 2025 [2] Strategic Partnerships and Initiatives - The company signed strategic cooperation agreements with several international brands, including Amorepacific's "Meishangxuan" and DHC, to enhance its presence in the health and personal care sectors [3] - The company has also partnered with Norwegian company ZoocaCalanus for exclusive distribution of a key ingredient in Greater China and established a strategic investment collaboration with AI ingredient development firm MetaNovas [2] Operational Efficiency - The company's agency operation business generated revenue of 764 million yuan in 2024, with an overall gross margin improvement of nearly 5 percentage points compared to the previous year [3] - During the Double Eleven shopping festival, nearly 50 agency-operated stores saw significant GMV growth, with multiple partner stores ranking in the top 5 of their categories [3] Market Performance - The company's stock has been well-received in the market, closing at 51.4 yuan per share on April 24, 2024, reflecting a 5.7% increase, and a year-to-date gain of over 84%, bringing its total market capitalization to 8.4 billion yuan [3]

新京报讯(记者张秀兰)在近日举行的科赴北京研发中心挂牌仪式上，北京市药品监督管理局二级巡视员 张殿祥表示，目前北京市化妆品行业呈现出良好发展态势，高质量发展水平不断提升。科赴北京研发中 心的成立，对吸引更多优秀化妆品企业落地北京产生示范效应。 科赴北京研发中心设立于科赴旗下北京大宝化妆品有限公司园区，旨在为科赴旗下包括大宝、艾惟诺等 在内的多个品牌护肤产品提供研发、注册、医学支持，同时携手科赴在上海、西安的科学研发网络，共 同承接科赴全球的科研资源和成果，并加速引入新品。目前，科赴北京研发中心正在开展或者支持的学 术项目包括：与北京大学生命科学学院携手开展皮肤细胞线粒体研究、科赴全球皮肤健康研究、针对中 国儿童的皮肤健康研究等。 张殿祥表示，"近年来，北京市药监局紧密围绕北京国际科技创新中心和'时尚之城'建设，不断优化监 管举措，优化营商环境，以'创新'为中心，重点打造企业生存与发展的核心驱动力，以首善标准加快推 进美丽经济产业发展。目前，北京市化妆品行业呈现出良好发展态势。科赴北京研发中心的成立，为整 个行业注入了新活力，对吸引更多优秀化妆品企业落地北京产生示范效应。" 中国香料香精化妆品工业协会理事长颜江 ...